Current Cancer Drug Targets, Volume 10 - Number 3

Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer

, 10(3): 268 - 278

N. Ahmed, K. Abubaker, J. Findlay and M. Quinn

DOI: 10.2174/156800910791190175

In Vivo Inhibition of the Estrogen Sulfatase Enzyme and Growth of DMBA-Induced Mammary Tumors by Melatonin

, 10(3): 279 - 286

A. Gonzalez, V. Alvarez-Garcia, C. Martinez-Campa, M.D. Mediavilla, C. Alonso-Gonzalez, E.J. Sanchez-Barcelo and S. Cos

DOI: 10.2174/156800910791190201

CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer

, 10(3): 287 - 306

J.L. Hao, P.J. Cozzi, A. Khatri, C.A. Power and Y. Li

DOI: 10.2174/156800910791190193

Persistent P21Cip1 Induction Mediates G1 Cell Cycle Arrest by Methylseleninic Acid in DU145 Prostate Cancer Cells

, 10(3): 307 - 318

Z. Wang, H.-J. Lee, Y. Chai, H. Hu, L. Wang, Y. Zhang, C. Jiang and J. Lu

DOI: 10.2174/156800910791190238

Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy

, 10(3): 319 - 331

A.S. Azmi, P.A. Philip, A. Aboukameel, Z. Wang, S. Banerjee, S.F. Zafar, A.-S. Goustin, K. Almhanna, D. Yang, F.H. Sarkar and R.M. Mohammad

DOI: 10.2174/156800910791190229

Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma

, 10(3): 332 - 342

I. Kenessey, M. Keszthelyi, Z. Kramer, J. Berta, A. Adam, J. Dobos, M. Mildner, B. Flachner, S. Cseh, G. Barna, B. Szokol, L. Orfi, G. Keri, B. Dome, W. Klepetko, J. Timar and J. Tovari

DOI: 10.2174/156800910791190184

A Novel Cancer Targeting Approach Based on Estrone Anchored Stealth Liposome for Site-Specific Breast Cancer Therapy

, 10(3): 343 - 353

S.R. Paliwal, R. Paliwal, N. Mishra, A. Mehta and S.P. Vyas

DOI: 10.2174/156800910791190210

Webmaster Contact:
Copyright © 2018 Bentham Science